Compared to those of the SAR combined with the CEA, CYFRA21-1, and NSE, the diagnostic rate and sensitivity of the SAR combined with the four serum lung cancer tumour markers were 85.7% and 83.5%, respectively, with an AUC of 0.927. The gene discussed is ENO2; the disease is lung carcinoma.